Cancer cells upregulate proangiogenic factors like angiopoietins (Ang), epidermal growth factor (EGF), fibroblast growth factor (FGF), interleukin 8 (IL-8) etc., to activate compensatory pathways to stimulate blood vessel formation [60,61]. This evidence concerns the gene CXCL8 and cancer.